Exon-Skipping ASOs: Restoring Function Through RNA…

What Exon-Skipping ASOs Are

Exon-skipping antisense oligonucleotides (ASOs) are synthetic molecules designed to alter the splicing of pre-mRNA, specifically targeting a particular exon for skipping during RNA processing. This technique is particularly useful in diseases caused by single-exon deletions or mutations, such as Duchenne muscular dystrophy.

By precisely modulating which exons are included in the final mRNA transcript, ASOs can restore reading frames and produce truncated but functional proteins that retain some of their original function.

How Exon-Skipping Works

The mechanism behind exon-skipping involves the binding of the ASO to a specific sequence in the pre-mRNA, which then interacts with the splicing machinery. This interaction can either enhance or inhibit the inclusion/exclusion of the targeted exon during RNA processing.

In the case of Duchenne muscular dystrophy (DMD), exon-51 skipping is a common approach where the ASO binds to and promotes the exclusion of exon 51, allowing for the restoration of reading frame continuity in the resulting mRNA.

live demo · related simulation● LIVE

Why It Matters

Exon-skipping ASOs are significant because they offer a targeted therapeutic strategy that can potentially correct genetic defects without altering the entire gene. This precision is crucial for diseases where a single exon mutation can lead to severe phenotypes.

Moreover, this approach has shown promising results in clinical trials and represents a step forward in personalized medicine, as it can be tailored to specific patient genotypes.

Real-World Applications

The use of exon-skipping ASOs has been particularly impactful for Duchenne muscular dystrophy. By restoring the reading frame and producing a truncated but functional dystrophin protein, patients can experience significant improvements in muscle function and quality of life.

Beyond DMD, this technology holds promise for other genetic disorders where single-exon mutations are responsible for disease pathogenesis.

Frequently asked questions

How do ASOs achieve exon skipping?

ASOs bind to specific sequences in the pre-mRNA and interact with the splicing machinery, either enhancing or inhibiting the inclusion of a targeted exon during RNA processing.

What are the potential side effects of using ASOs for gene therapy?

Potential side effects include off-target effects, immune responses to the ASO itself, and the possibility of inducing mutations in other regions of the genome due to the binding mechanism.

Can exon-skipping be used for any genetic disorder?

Exon-skipping is most effective for disorders caused by single-exon deletions or mutations. It can be applied to various conditions, but its success depends on the specific genetic defect and the availability of a suitable ASO.

What are the current limitations of exon-skipping ASOs?

Current limitations include the need for precise targeting, potential off-target effects, and the challenge of achieving consistent efficacy across different patient populations.

Try it live

Everything above runs in your browser — open Exon-Skipping ASO Reading-Frame Repair and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Exon-Skipping ASO Reading-Frame Repair simulation

Exon-Skipping ASOs: Restoring Function Through RNA Manipulation